Observational Study of AlgometRx Nociometer for Pediatric IBD
This study is looking at a new device called the AlgometRx Nociometer to better understand inflammation in children and young adults with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The device measures your sensory response to help doctors assess disease activity and potentially guide treatment. We are looking for participants aged 6 to 21 who have a confirmed IBD diagnosis. The main goal is to measure a "nociceptive index" (a way to measure pain or sensitivity) using this device over one year to see how well it works. The study is currently unclear on its recruitment status and plans to enroll 60 participants.
- Study design
- This is an observational study, meaning researchers will be watching and collecting information without giving a specific treatment. It aims to enroll 60 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary measurement for this study is taken at 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Therapeutic Endpoint in Pediatric IBD Conditions
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- The primary objective of this study is the measurement of the nociceptive index for clinical output.1 Year